Spectrum Pharmaceuticals to Raise $21 Million from Institutional Investors at $7.1525 Per Share (Business Wire)
Posted on June 30, 2009 at 6:23 pm in Online Trading News
IRVINE, Calif.—-Spectrum Pharmaceuticals, Inc. , a commercial-stage biotechnology company with a focus in oncology, today announced that it has received commitments from institutional investors to purchase $21 million of securities in a registered direct offering.
More: continued here
